Connect with us

Technology

NueCell Bio Announces its Launch as a New Translational Partner for Cell Therapies with Unique Expertise to Accelerate Treatments from Discovery into GMP Manufacturing

Published

on

SAN DIEGO, Aug. 5, 2026 /PRNewswire/ — NueCell Bio, a newly established cell therapy science and development services company that utilizes proprietary modular translational development solutions focused on advancing modern cell therapies from scientific discovery through clinical readiness, today announced its launch as a specialist partner uniquely positioned to advance and accelerate cell-based treatments to patients.

NueCell Bio is led by a team possessing unprecedented experience in the advanced therapies market. The team’s industry-leading expertise in supporting customers developing novel cell therapies positions NueCell Bio to offer customizable modular technologies to engineer cells and develop scalable, GMP-ready manufacturing processes and analytics for a wide range of cell therapies. NueCell Bio works across a broad spectrum of groundbreaking science in this field, including CAR-T, stem cells, iPSC-derived therapies, gene-edited cells, and tissue repair platforms – supporting both autologous and allogeneic products.

NueCell Bio is headquartered in the Sorrento Valley area of San Diego – a leading hub for biotechnology and advanced therapy development – in a 26,300 square-foot, state-of-the-art facility that specializes in translational services for cell therapy.

“Advanced therapies, including cell therapies, are expanding rapidly across the United States, Europe, Japan, South Korea, and emerging biotechnology markets,” said Michael Wourms, Chief Executive Officer of NueCell Bio. “The industry does not suffer from a shortage of scientific breakthroughs, it suffers from a difficulty in efficiently converting these breakthroughs into therapies that can be evaluated, manufactured, and ultimately delivered to patients. That translational phase is where NueCell Bio is focused. By combining NueCell’s flexible and modular translational development solutions with scientific expertise, analytical capabilities, and a proven track record, we believe we are uniquely positioned to help innovators advance the next generation of cellular therapies for cancer, immune-mediated diseases, tissue repair and regeneration, and other areas of significant unmet medical need.”

“NueCell Bio is distinctively positioned to advance cell therapies from early discovery through clinical development,” said Dr. Uma Lakshmipathy, Co-founder and Chief Science Officer. “Cell therapies have been proven to work and are commercially available, but manufacturing them at scale is still slow and expensive, largely because each therapy is biologically unique. The most promising therapies often face the greatest development complexity. Every program follows a different path, and the scientific, analytical, and development challenges that create risk for one company may be very different for another. Our role is to understand where each program is today, identify what is needed to move it forward, and apply the right expertise and resources at the appropriate time to help accelerate its path towards clinical readiness. By combining modular technology stacks of scientific, analytical, process development, and manufacturing-enabling capabilities, NueCell Bio is uniquely positioned to help innovators navigate critical development challenges and advance promising therapies more efficiently to reach patients faster.”

Renowned University of Pennsylvania Professor, Dr. Bruce Levine, a member of NueCell Bio’s Scientific Advisory Board, said, “The ecosystem of advanced therapies I have been part of for many years is moving rapidly and NueCell Bio helps meet the demand by supporting the development of life-altering and life-saving treatments that were previously only a distant hope in many challenging areas of medicine. To reach more patients, the future of cell therapy lies in expanding beyond oncology towards additional broad indications, while still addressing low-incidence diseases. To support this goal, the incorporation of precision engineering, efficient manufacturing processes and advanced analytics is essential.”

“The ability to genetically engineer cells to have the characteristics to treat specific diseases is key, but another very important aspect is successfully advancing these programs from lab research into a GMP manufacturing process that is capable of consistently delivering cells in sufficient quantities and with required characteristics and viability,” said Dr. Gabor Veres, a member of NueCell Bio’s Scientific Advisory Board. “With the expertise of our team and state-of-the-art capabilities, NueCell Bio is well positioned to support customers by developing reliable, consistent and scalable processes suited to clinical manufacturing and future commercialization.”

Addressing the acquisition and the future, Dr. Richard Snyder, Chair of the Board and Co-founder of NueCell Bio, said, “I am incredibly excited by how this business brings together such an extraordinary caliber of leaders in the field, along with the team and assets transitioning to NueCell Bio. Beyond this, our team’s significant industry networks are an equally strong factor in establishing NueCell as a highly differentiated cell therapy services business positioned to address the needs of current and future customers.”

In connection with the transaction, Kineticos Life Sciences served as exclusive advisor to NueCell Bio, with Goodwin Procter LLP serving as legal counsel.

About NueCell Bio

NueCell Bio is a San Diego-based company that works with academic institutions, biotechnology companies and pharmaceutical companies to advance cell therapies from concept and early research into clinical development. Our team brings deep expertise in biology, cell engineering, bioprocessing, and advanced technology integration, supported by modular technology stacks that can be tailored to each program.

NueCell Bio gives clients access to experienced design, development and CMC expertise. By combining scientific excellence, strong quality systems, scalable operations, and ‘customer-first’ engagement, NueCell Bio helps accelerate the journey from scientific discovery to clinical delivery. For more information, visit www.NueCellBio.com 

Media contact:

Connor Halverson
Tel: +1 212 366 4455
Email: connor@thatsnice.com 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/nuecell-bio-announces-its-launch-as-a-new-translational-partner-for-cell-therapies-with-unique-expertise-to-accelerate-treatments-from-discovery-into-gmp-manufacturing-302841793.html

Continue Reading

Technology

Guidepoint Relocates Shanghai Office to Strengthen Regional Presence

Published

on

By

SHANGHAI, Sept. 21, 2026 /PRNewswire/ — Guidepoint, a global pioneer in access to expert insight, today announced the relocation of its Shanghai office to the Bund Center on East Yan’an Road.

Building on more than a decade of sustained growth in China, the relocation positions Guidepoint in the heart of Shanghai’s business district, bringing the firm closer to the clients and partners it serves while providing a modern, collaborative workspace for its growing team.

“Research today has evolved beyond standalone expert calls to more connected, AI-enabled workflows,” said Michael Wang, Guidepoint’s Director and Head of China. “The new Shanghai office brings together capabilities across research, product innovation, compliance, and operations, reinforcing Guidepoint’s commitment to delivering source-backed insight through rigorous standards, transparency, and integrity.”

“Shanghai remains one of the world’s most influential centers for business and finance, connecting decision-makers across industries and markets,” said Chris Bonsi, Head of APAC. “This relocation reinforces our long-term commitment to the region and strengthens our ability to serve clients and attract top talent.”

As demand for expert-led, source-backed insight continues to grow, Guidepoint is focused on expanding its research capabilities by combining expert knowledge, proprietary content, and technology-enabled workflows to help clients move from uncertainty to conviction with greater speed and confidence.

About Guidepoint
Guidepoint provides real-time access to expert insights, combining human expertise with AI-powered research tools to deliver knowledge at scale. Backed by a global network of more than 2M+ subject-matter experts, Guidepoint equips institutional investors, consulting firms, and corporations with the context they need across companies, markets, and trends. Through live, asynchronous, and agentic workflows, Guidepoint embeds expert knowledge directly into decision-making, turning answers into action when timing matters most.

More on Guidepoint

View original content:https://www.prnewswire.com/apac/news-releases/guidepoint-relocates-shanghai-office-to-strengthen-regional-presence-302880268.html

SOURCE Guidepoint

Continue Reading

Technology

Reap Launches First Ever Managed Fraud and Risk Service for Card Programs

Published

on

By

Reap Sentry configures and manages fraud controls for clients’ card programs, eliminating the need for additional monitoring tools or in-house fraud specialists.

HONG KONG, Sept. 21, 2026 /PRNewswire/ — Reap, a global financial technology company that enables financial connectivity and access for businesses worldwide through stablecoin-enabled infrastructure, today announced the launch of Reap Sentry, a managed card fraud and risk service. Through Sentry, Reap manages a client’s end-to-end transaction risk management – from configuring fraud rules and screening authorisations in real time to investigating alerts, processing chargebacks, and reporting confirmed fraud to Visa. Clients do not need to build or license additional fraud-monitoring tools, or hire a dedicated fraud team.

Payment card fraud losses worldwide totalled USD 33.41 billion in 2024 (The Nilson Report, January 2026), tied to global card volume of USD 51.920 trillion (The Nilson Report, January 2026). Every card in circulation is a live payment instrument, with authorisation decisions made in milliseconds. Fraud must be stopped at the point of authorisation, not afterwards, as the knock-on costs of fraud can often exceed the value of the fraud itself. Meanwhile, evolving attack patterns make fraud management an ongoing operational function.

Built on the technology within Reap’s issuing portfolio, Sentry combines the fraud policy, tooling, and day-to-day operations required to manage transaction risk effectively. Having issued millions of cards over eight years of card issuance, Reap brings to Sentry controls informed by fraud patterns observed across its entire issuing portfolio. These controls are tailored to each client’s business profile, including its cardholder segments, geographic footprint, and stated risk appetite.

Sentry conducts ongoing screening and declines suspected fraud in real time at authorisation; triages and investigates alerts; and continuously updates controls as new threats emerge, including BIN attacks and merchant breaches. The service also processes and represents chargebacks submitted by clients, reports confirmed fraud, and provides program performance reporting on an agreed cadence. Controls are reviewed and refined as each program evolves, without requiring client intervention. Clients can integrate with Sentry through a single Reap API.

Reap protects the authorisation layer it operates and observes, while clients retain responsibility for the cardholder relationship and key first-party fraud entry points, including onboarding, identity verification and account access.

“Most companies launching a card programme have to build a fraud function from day one. Doing so requires specialist tooling, dedicated expertise and several months of preparation before they can safely issue a single card, by which point the threat landscape may already have shifted. That is rarely how a team wants its first months to go.” said Harris Leow, Head of Product, Reap. “Sentry takes on that entire card fraud function: our controls, data and specialists, tailored to each card programme.”

Sentry is available to new Reap card issuing clients and to existing clients at contract renewal, on Reap’s own API.

To find out more about Sentry, visit our website: https://reap.global/products/sentry-fraud-risk-management

About Reap
Reap is a global financial technology company that enables financial connectivity and access for businesses worldwide through stablecoin-enabled infrastructure. We transform the financial landscape through more efficient money movement by merging traditional finance with digital assets, bridging disparate economies and connecting key financial markets.

Reap was an early leader in Asia to incorporate stablecoins into our solutions. In 2025, Reap processed billions in stablecoin-funded transaction flows. From stablecoin-enabled corporate cards to cross-border payments, we streamline financial operations and empower companies to scale with our integrated business accounts and embedded finance solutions.

Founded and headquartered in Hong Kong, Reap employs 300 people worldwide. More information about Reap can be found at reap.global.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/reap-launches-first-ever-managed-fraud-and-risk-service-for-card-programs-302883396.html

SOURCE Reap

Continue Reading

Technology

Envision Energy Powers Morocco’s First Large-Scale Battery Storage System at OCP’s Benguerir Mining Site

Published

on

By

BENGUERIR, Morocco, Sept. 21, 2026 /PRNewswire/ — Envision Energy, a global leader in green technology, today announced the successful energisation of Morocco’s first large-scale lithium iron phosphate (LFP) battery energy storage system at OCP Green Energy’s Benguerir mining site. The 25 MW / 125 MWh system was supplied and commissioned by Envision Energy under a contract signed in late 2025, and is now undergoing testing before entering commercial operation.

Envision Energy provided the full storage system and led the commissioning work, integrating the BESS with the site’s solar generation, grid conditions and industrial load profile. The system is designed to shift surplus solar power from daytime generation to peak consumption hours, reducing the site’s peak-hour electricity bill by approximately 25%.

With five hours of storage capacity, the BESS functions as an industrial energy management tool rather than a short-duration grid asset. It is supported by USD 20 million from the Clean Technology Fund, managed through the African Development Bank Group, and is designed for a 25-year lifetime with daily charge-discharge cycles. For OCP, the value lies not in battery capacity, but in the system’s ability to reduce peak-hour costs over a 25-year operating life.

“The successful energisation of Morocco’s first large-scale battery storage project demonstrates the reliability, flexibility and cost-effectiveness of integrated renewable-plus-storage solutions in industrial applications,” said John Lee, General Manager of Envision Energy for the Middle East and Africa. “Envision is proud to be part of this landmark project and to contribute green technology to Morocco’s energy transition.”

As highlighted in OCP Group’s official press release announcing the milestone, Omar Kadir, CEO of OCP Green Energy, said: Storage is the natural extension of our energy strategy. It allows us to reconcile the variable output of renewable energy with the continuous needs of our industrial platforms, while strengthening the reliability of our energy supply. Beyond OCP Group’s own needs, this technology paves the way for a more harmonious integration of renewable energy into the national power system. By bringing greater flexibility and resilience to the grid, it will help accelerate the deployment of renewable capacity.”

The project marks a significant milestone for battery storage and industrial decarbonisation in Morocco. It supports the country’s target of achieving 52% of installed electricity capacity from renewable sources by 2030 and serves as a benchmark for industrial decarbonisation across Africa.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/envision-energy-powers-moroccos-first-large-scale-battery-storage-system-at-ocps-benguerir-mining-site-302884224.html

Continue Reading

Trending